Watch! The ADDRESS-LC Trial Webinar
The ADDRESS-LC trial was designed to assess the potential impact of bezisterim on cognitive impairment/brain fog and fatigue in individuals with Long Covid and is currently recruiting people aged 18-64 […]
Day: July 23, 2025